<DOC>
	<DOCNO>NCT00555191</DOCNO>
	<brief_summary>Different publish study show possible co-variation leakage fructose great bowel exacerbation irritable bowel syndrome ( IBS ) symptom . The aim FINN trial study role fructose malabsorption patient IBS order evaluate different diagnostic criterion fructose malabsorption time study effect diet treatment cohort patient estimate prevalence fructose malabsorption .</brief_summary>
	<brief_title>Fructose Malabsorption Northern Norway</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Malabsorption Syndromes</mesh_term>
	<criteria>IBS patient satisfy ROME 2 diagnostic criterion Seriously ill Organic abdominal disease Other functional bowel disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>fructose</keyword>
	<keyword>Irritable bowel syndrome</keyword>
	<keyword>malabsorption</keyword>
	<keyword>Glut5 transporter gene</keyword>
</DOC>